IBDEI1IF ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24146,1,4,0)
 ;;=4^L03.323
 ;;^UTILITY(U,$J,358.3,24146,2)
 ;;=^5009057
 ;;^UTILITY(U,$J,358.3,24147,0)
 ;;=L03.324^^107^1201^18
 ;;^UTILITY(U,$J,358.3,24147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24147,1,3,0)
 ;;=3^Acute Lymphangitis of Groin
 ;;^UTILITY(U,$J,358.3,24147,1,4,0)
 ;;=4^L03.324
 ;;^UTILITY(U,$J,358.3,24147,2)
 ;;=^5009058
 ;;^UTILITY(U,$J,358.3,24148,0)
 ;;=L03.325^^107^1201^24
 ;;^UTILITY(U,$J,358.3,24148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24148,1,3,0)
 ;;=3^Acute Lymphangitis of Perineum
 ;;^UTILITY(U,$J,358.3,24148,1,4,0)
 ;;=4^L03.325
 ;;^UTILITY(U,$J,358.3,24148,2)
 ;;=^5009059
 ;;^UTILITY(U,$J,358.3,24149,0)
 ;;=L03.326^^107^1201^30
 ;;^UTILITY(U,$J,358.3,24149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24149,1,3,0)
 ;;=3^Acute Lymphangitis of Umbilicus
 ;;^UTILITY(U,$J,358.3,24149,1,4,0)
 ;;=4^L03.326
 ;;^UTILITY(U,$J,358.3,24149,2)
 ;;=^5009060
 ;;^UTILITY(U,$J,358.3,24150,0)
 ;;=L03.329^^107^1201^29
 ;;^UTILITY(U,$J,358.3,24150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24150,1,3,0)
 ;;=3^Acute Lymphangitis of Trunk,Unspec
 ;;^UTILITY(U,$J,358.3,24150,1,4,0)
 ;;=4^L03.329
 ;;^UTILITY(U,$J,358.3,24150,2)
 ;;=^5009062
 ;;^UTILITY(U,$J,358.3,24151,0)
 ;;=L08.9^^107^1201^171
 ;;^UTILITY(U,$J,358.3,24151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24151,1,3,0)
 ;;=3^Local Infection of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,24151,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,24151,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,24152,0)
 ;;=L11.0^^107^1201^10
 ;;^UTILITY(U,$J,358.3,24152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24152,1,3,0)
 ;;=3^Acquired Keratosis Follicularis
 ;;^UTILITY(U,$J,358.3,24152,1,4,0)
 ;;=4^L11.0
 ;;^UTILITY(U,$J,358.3,24152,2)
 ;;=^5009091
 ;;^UTILITY(U,$J,358.3,24153,0)
 ;;=L20.0^^107^1201^91
 ;;^UTILITY(U,$J,358.3,24153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24153,1,3,0)
 ;;=3^Besnier's Prurigo
 ;;^UTILITY(U,$J,358.3,24153,1,4,0)
 ;;=4^L20.0
 ;;^UTILITY(U,$J,358.3,24153,2)
 ;;=^5009107
 ;;^UTILITY(U,$J,358.3,24154,0)
 ;;=L20.81^^107^1201^88
 ;;^UTILITY(U,$J,358.3,24154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24154,1,3,0)
 ;;=3^Atopic Neurodermatitis
 ;;^UTILITY(U,$J,358.3,24154,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,24154,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,24155,0)
 ;;=L20.82^^107^1201^153
 ;;^UTILITY(U,$J,358.3,24155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24155,1,3,0)
 ;;=3^Flexural Eczema
 ;;^UTILITY(U,$J,358.3,24155,1,4,0)
 ;;=4^L20.82
 ;;^UTILITY(U,$J,358.3,24155,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,24156,0)
 ;;=L20.84^^107^1201^165
 ;;^UTILITY(U,$J,358.3,24156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24156,1,3,0)
 ;;=3^Intrinsic Eczema
 ;;^UTILITY(U,$J,358.3,24156,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,24156,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,24157,0)
 ;;=L20.89^^107^1201^86
 ;;^UTILITY(U,$J,358.3,24157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24157,1,3,0)
 ;;=3^Atopic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,24157,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,24157,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,24158,0)
 ;;=L20.9^^107^1201^87
 ;;^UTILITY(U,$J,358.3,24158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24158,1,3,0)
 ;;=3^Atopic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,24158,1,4,0)
 ;;=4^L20.9
 ;;^UTILITY(U,$J,358.3,24158,2)
 ;;=^5009113
 ;;^UTILITY(U,$J,358.3,24159,0)
 ;;=L21.8^^107^1201^302
